These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 15795562)

  • 1. Statins and cardiovascular risks.
    Lee JW
    Int Anesthesiol Clin; 2005; 43(2):55-68. PubMed ID: 15795562
    [No Abstract]   [Full Text] [Related]  

  • 2. Genetic determinants of response to statins.
    Peters BJ; Klungel OH; de Boer A; Maitland-van der Zee AH
    Expert Rev Cardiovasc Ther; 2009 Aug; 7(8):977-83. PubMed ID: 19673675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Commentary: Statins, COVID-19, and coronary artery disease: killing two birds with one stone.
    Ganjali S; Bianconi V; Penson PE; Pirro M; Banach M; Watts GF; Sahebkar A
    Metabolism; 2020 Dec; 113():154375. PubMed ID: 32976855
    [No Abstract]   [Full Text] [Related]  

  • 4. Lipid management for the prevention of cardiovascular disease.
    Schaefer JR
    Curr Pharm Des; 2011; 17(9):852-60. PubMed ID: 21418030
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Case Against Coronary Artery Calcium Scoring for Cardiovascular Disease Risk Assessment.
    Mandrola J; Foy A
    Am Fam Physician; 2019 Dec; 100(12):734-735. PubMed ID: 31845777
    [No Abstract]   [Full Text] [Related]  

  • 6. Calcium scores are the key to predicting cardiovascular risk.
    Lewis GR
    N Z Med J; 2003 Dec; 116(1187):U720. PubMed ID: 14752543
    [No Abstract]   [Full Text] [Related]  

  • 7. [Treatment with statins for the reduction of cardiovascular risk].
    Chiariello M
    Ital Heart J Suppl; 2001 Mar; 2(3):221-3. PubMed ID: 11307779
    [No Abstract]   [Full Text] [Related]  

  • 8. Can statins mitigate the adverse cardiovascular effects of smoking?
    Gouni-Berthold I; Rizzo M
    Curr Vasc Pharmacol; 2013 Sep; 11(5):777-8. PubMed ID: 23256877
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical significance of mild lipid-lowering by statins for prevention of cardiovascular disease in Japanese high-risk patients.
    Miyazaki T; Daida H
    Circ J; 2010 Apr; 74(4):630-1. PubMed ID: 20234101
    [No Abstract]   [Full Text] [Related]  

  • 10. The influence of antibiotics and statins on inflammation in coronary disease.
    Stojanović R; Vasiljević Z; Prostran M; Radovanović M; Stefanović B; Radovanović N; Janković J; Lakicević M; Mitrović P; Lasica R; Nesić Z; Todorović Z; Stojanov M
    Vojnosanit Pregl; 2005 Sep; 62(9):661-70. PubMed ID: 16229209
    [No Abstract]   [Full Text] [Related]  

  • 11. Cholesterol Lowering in 2015: Still Answering Questions About How and in Whom.
    Greenland P; Lauer MS
    JAMA; 2015 Jul; 314(2):127-8. PubMed ID: 26172891
    [No Abstract]   [Full Text] [Related]  

  • 12. Statins.
    Ratchford EV; Martin SS
    Vasc Med; 2017 Oct; 22(5):442-445. PubMed ID: 28803537
    [No Abstract]   [Full Text] [Related]  

  • 13. Beyond the coronary arteries: possible benefits of statin drugs. Part I: Meet the statins.
    Harv Mens Health Watch; 2011 Apr; 15(9):5-7. PubMed ID: 21560292
    [No Abstract]   [Full Text] [Related]  

  • 14. Statin treatment in patients with metabolic syndrome and coronary artery disease.
    Ishihara M
    Circ J; 2009 Nov; 73(11):2013-4. PubMed ID: 19851028
    [No Abstract]   [Full Text] [Related]  

  • 15. Use of controversial ACC/AHA guidelines for statin therapy is supported by US studies.
    McCarthy M
    BMJ; 2015 Jul; 351():h3902. PubMed ID: 26194997
    [No Abstract]   [Full Text] [Related]  

  • 16. Statins: have we found the Holy Grail?
    Jeger R; Dieterle T
    Swiss Med Wkly; 2012; 142():w13515. PubMed ID: 22315166
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effects of statins on coronary artery disease. Review of the recent publications].
    Bednarz B
    Przegl Lek; 2003; 60(1):27-9. PubMed ID: 12884643
    [TBL] [Abstract][Full Text] [Related]  

  • 18. All for Statins and Statins for All; An Update.
    Agouridis AP; Elisaf MS; Nair DR; Mikhailidis DP
    Curr Pharm Des; 2016; 22(1):18-27. PubMed ID: 26548311
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 3-Hydroxy-3-methylglutaryl coenzyme a (HMG-CoA) reductase inhibitors (statins), atherosclerosis and coronary syndromes.
    Blum A; Simsolo C; Hasin Y
    Atherosclerosis; 2004 Jul; 175(1):1-5. PubMed ID: 15186940
    [No Abstract]   [Full Text] [Related]  

  • 20. Use of statins to reduce the risk of cardiovascular disease in adults.
    Ford H
    Nurs Stand; 2013 May 29-Jun 4; 27(39):48-56; quiz 58. PubMed ID: 23855160
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.